Skip to main content
. 2024 Sep 9;14(9):1138. doi: 10.3390/life14091138

Table 3.

Curcumin clinical studies for the management of microbial diseases.

Disease Number of Participants Dose Result Reference
Chronic periodontitis 23 1% curcumin solution, 0.2% chlorhexidine gluconate, and saline were used as irrigants The curcumin group reduced bleeding scores more effectively than the control group [125]
Oral plaque 27 LED lighting generating blue light with a curcumin concentration of 30 mg/L Curcumin possesses the capability to disintegrate mouth plaque; salivary microbes can be reduced using the blue LED device that contains curcumin [126]
Periodontitis 25 Locally applied 1% curcumin gel to treat periodontitis A curcumin gel application dramatically lowered the periopathogen microbiological count; when used after scaling and root planing, curcumin gel effectively inhibits the growth of oral germs [127]
Peptic ulcer 30 Curcumin (500 mg) along with piperine (5 mg) Dyspepsia symptoms improved [128]
Peptic ulcer 21 Clarithromycin (500 mg) + amoxicillin (1 g) + esomeperazole (20 mg) + curcumin (500 mg) Reduction in pro-inflammatory IL-1B level; improved healing [129]
Chronic gastritis 24 Omeprazole (20 mg) + amoxicillin (1 g) + metronidazole (800 mg) + curcumin (700 mg) Reduction in oxidative DNA damage; improved clinical symptoms [130]
COVID-19 70 mild to severe COVID-19 patients Patients took a dietary supplement containing 2.5 milligrams of bioperine and 252 milligrams of curcumin Reduced the length of hospital stays for patients with moderate to severe symptoms, showed early symptomatic recovery [131]
COVID-19 30 mild to moderate COVID-19 patients Patients in the Sinacurcumin® soft gel 40 mg group took two gels with meals: breakfast and dinner Symptoms such as chills, cough, and smell/taste disturbances cleared up significantly faster than in the control group, with the exception of sore throat [132]
COVID-19 115 Dietary supplement: palmitoylethanolamideDietary supplement: curcumin Curcumin supplementation reduced the proinflammatory response in patients recently diagnosed with COVID-19 [76]